Chemotherapy of high-grade gliomas: Beginning of a new era or the end of the old?

European Journal of Cancer Part A

Volumn 32, Issue 13, 1996, Pages 2193-2194

  Brada, M ^a   Sharpe, G ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE;

CANCER CHEMOTHERAPY; DRUG CHOICE; DRUG EFFICACY; EDITORIAL; GLIOMA; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 0030447782     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00400-5     Document Type: Editorial

References (7)

1. D Osoba N Aaronson K Sneeuw M-A Hsu W Yung M Brada E Newlands The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer specific questionnaires Qual Life Res 5 1196 139 150
2. R Grant J Slattery A Gregor IR Whittle Recording neurological impairment in clinical trials of glioma J Neuro-oncol 19 1994 37 49
3. LC Brazil R Thomas R Laing F Hines G Gurrero S Ashley M Brada Verbally administered Barthel Index as functional assessment in brain tumour patients J Neuro-Oncol 21 1996 71
4. HA Fine KB Dear JS Loeffler P Black CG P Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults Cancer 71 1993 2585 2597
5. S Stenning L Freedman N Bleehen An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma Br J Cancer 56 1987 89
6. DR MacDonald TL Cascino SCJ Schold G Cairncross Response criteria for phase II studies of supratentorial malignant glioma J Clin Oncol 8 1990 1277 1280
7. B Rajan GM Ross CC Lim Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy Eur J Cancer 30A 1994 1809 1815